Target intelligence / Profile preview

Endogenous signaling pathways and gene regulatory networks

Molecular classification
Other
01

Overview

Endogenous signaling pathways and gene regulatory networks represent the integrated systems of molecular communication and control within a cell. These networks consist of signaling cascades, such as those mediated by kinases and second messengers, coupled with the transcriptional machinery that regulates gene expression (Davidson, 2010). They are responsible for processing environmental cues to execute biological programs like cell division, differentiation, and programmed cell death (Alberts et al., 2014). Dysregulation of these pathways is a fundamental driver of human disease, particularly in oncology where "rewired" networks promote survival and metastasis (Hanahan & Weinberg, 2011). While drug discovery typically focuses on individual proteins as targets, the therapeutic outcome is a result of modulating the broader network context. Challenges in targeting these systems include pathway crosstalk and the emergence of resistance through compensatory feedback loops (Levine et al., 2017). Modern therapeutic strategies often employ combination therapies to simultaneously inhibit multiple nodes within a network to achieve better efficacy.

Other names
Cellular signaling networksGene regulatory circuitsSignal transduction pathwaysIntracellular signaling cascadesBiological networks
02

Mechanism of action

Pharmacological agents modulate these networks by binding to specific receptors, enzymes, or transcription factors, thereby altering the flow of biochemical information and gene expression (Levine et al., 2017).

03

Biological functions

Signal transductionGene expression regulationCell cycle controlApoptosisCell differentiationHomeostasis
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseMetabolic disorderAutoimmune disease
05

Safety considerations

Network crosstalk leading to unintended side effectsFeedback loops causing drug resistancePleiotropic effectsSystemic toxicity due to lack of specificity for a single pathway
06

Interacting drugs

5 more in the full profile.

07

Biomarkers

Transcriptomic signaturesProteomic profilesPhosphorylation statesGene expression patterns

Beyond the preview

Go deeper on Endogenous signaling pathways and gene regulatory networks.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endogenous signaling pathways and gene regulatory networks.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call